MANNKIND CORP Cash and Restricted Cash
MANNKIND CORP (MNKD) had Cash and Restricted Cash of $97.38 million as of 2024-06-30, per its 10-Q filed 2024-08-07.
Discontinued › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2024-08-07
- 2024-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $97.38M.
- 2023-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $238.48M.
- 2018-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $27.23M.
- 2017-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $48.35M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2024-06-30 | $97.38M 10-Q · filed 2024-08-07 |
| 2023-12-31 | $238.48M 10-Q · filed 2024-08-07 |
| 2018-03-31 | $27.23M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $48.35M 10-Q · filed 2018-05-09 |
| 2017-03-31 | $47.98M 10-Q · filed 2018-05-09 |
| 2016-12-31 | $22.89M 10-Q · filed 2018-05-09 |
| 2015-12-31 | $59.07M 10-K · filed 2018-02-27 |
| 2014-12-31 | $120.84M 10-K · filed 2018-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |